Clopidogrel and Aspirin versus Aspirin Alone for Stroke Prevention: A Meta-Analysis

被引:12
|
作者
Tan, Shuai [1 ]
Xiao, Xiaojuan [2 ]
Ma, Hanyu [3 ]
Zhang, Zhaohui [4 ]
Chen, Jiangbo [5 ]
Ding, Lei [6 ]
Yu, Shenping [2 ]
Xu, Rulin [7 ]
Yang, Shiliang [1 ]
Huang, Xinyi [1 ]
Hong, Hua [1 ]
机构
[1] Sun Yat Sen Univ, Affiliated Hosp 1, Dept Neurol, Guangzhou 510080, Guangdong, Peoples R China
[2] Sun Yat Sen Univ, Affiliated Hosp 1, Dept Radiol, Guangzhou 510080, Guangdong, Peoples R China
[3] Sun Yat Sen Univ, Affiliated Hosp 1, Dept Pathol, Guangzhou 510080, Guangdong, Peoples R China
[4] Sun Yat Sen Univ, Affiliated Hosp 1, Dept Pancreatobiliary Surg, Guangzhou 510080, Guangdong, Peoples R China
[5] Sun Yat Sen Univ, Affiliated Hosp 1, Dept Intervent Radiol, Guangzhou 510080, Guangdong, Peoples R China
[6] Sun Yat Sen Univ, Affiliated Hosp 1, Dept Thorac Surg, Guangzhou 510080, Guangdong, Peoples R China
[7] Sun Yat Sen Univ, Affiliated Hosp 1, Dept Cardiol, Guangzhou 510080, Guangdong, Peoples R China
来源
PLOS ONE | 2015年 / 10卷 / 08期
关键词
TRANSIENT ISCHEMIC ATTACK; CEREBRAL INFARCTION; RECURRENCE; RISK; SURVIVAL;
D O I
10.1371/journal.pone.0135372
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Background and Purpose Antiplatelet therapy is widely used for the primary or secondary prevention of stroke. Drugs like clopidogrel have emerged as alternatives for traditional antiplatelet therapy, and dual therapy with clopidogrel and aspirin is of particular interest. We conducted this meta-analysis to systematically review studies about dual therapy comparing monotherapy with aspirin alone. Methods Randomized controlled trials were searched in PubMed (1966-May, 2015), EMBASE (1947-May, 2015), the Cochrane Central Register of Controlled Trials (CENTRAL) (1948-May, 2015), WHO International Clinical Trial (ICTRP) (2004-May, 2015), China Biology Medicine disc (CBM disc) (1978-May, 2015) and were included into the final analysis according to the definite inclusion criteria mentioned in the study selection section. Risk ratio (RR) was pooled with 95% confidence interval (CI) for dichotomous data. The heterogeneity was considered significant if the chi(2) test was significant (P value < 0.10) or the I-2 > 50.00%. Subgroup analyses were carried out on the long and short time periods, the race and region. Results We included 5 studies involving 24,084 patients. A pooled analysis showed that dual therapy with clopidogrel and aspirin had a lower stroke incidence than monotherapy in both the short term and long term (RR = 0.69, 95% CI: 0.59-0.82, P <0.05; RR = 0.84, 95% CI: 0.72-0.98, P = 0.03, respectively). With regard to safety, dual therapy had a higher risk of bleeding than monotherapy for both periods (RR = 1.51, 95% CI: 1.03-2.23, P = 0.04; RR = 1.54, 95% CI: 1.32-1.79, P<0.05, respectively). Conclusions Dual therapy with clopidogrel and aspirin could be a preferable choice to prevent stroke in patients who have had a previous stroke or transient ischemic attack, as well as those who are at high risk for stroke. And the effect of dual therapy seems to be more obvious for short-term. However, it is associated with a higher risk of bleeding.
引用
收藏
页数:14
相关论文
共 50 条
  • [31] Clopidogrel plus aspirin versus aspirin alone for preventing cardiovascular events
    Squizzato, Alessandro
    Bellesini, Marta
    Takeda, Andrea
    Middeldorp, Saskia
    Donadini, Marco Paolo
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2017, (12):
  • [32] COMPARISON OF ASPIRIN VERSUS ASPIRIN PLUS CLOPIDOGREL / DIPYRIDAMOLE FOR SECONDARY PREVENTION OF INTRACRANIAL ARTERIAL STENOSIS. A SYSTEMATIC REVIEW AND META-ANALYSIS
    Tzinas, A. T.
    Evangeliou, A. P.
    Papadopoulos, C.
    Tzikas, S.
    ATHEROSCLEROSIS, 2020, 315 : E233 - E234
  • [33] Clopidogrel plus aspirin versus aspirin alone for preventing cardiovascular disease
    Squizzato, Alessandro
    Keller, Tymen
    Romualdi, Erica
    Middeldorp, Saskia
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2011, (01):
  • [34] Benefits and risks of clopidogrel versus aspirin monotherapy for acute ischemic stroke - a systematic review and meta-analysis
    Girotra, S.
    Lou, M.
    Hu, B.
    Liu, L.
    Pack, D.
    Sayre, T.
    CEREBROVASCULAR DISEASES, 2018, 45 : 136 - 136
  • [35] Effect of addition of clopidogrel to aspirin on stroke incidence: Meta-analysis of randomized trials
    Palacio, Santiago
    Hart, Robert G.
    Pearce, Lesly A.
    Anderson, David C.
    Sharma, Mukul
    Birnbaum, Lee A.
    Benavente, Oscar R.
    INTERNATIONAL JOURNAL OF STROKE, 2015, 10 (05) : 686 - 691
  • [36] Effect Of Addition Of Clopidogrel To Aspirin On Stroke Incidence: Meta-analysis Of Randomized Trials
    Palacio, Santiago
    Hart, Robert G.
    Pearce, Lesly A.
    Anderson, David C.
    Sharma, Mukul
    Birnbaum, Lee A.
    Benavente, Oscar R.
    STROKE, 2013, 44 (02)
  • [37] Clopidogrel plus aspirin versus aspirin alone for preventing early neurological deterioration in patients with acute ischemic stroke
    He, Fan
    Xia, Cheng
    Zhang, Jing-Hua
    Li, Xiao-Qiu
    Zhou, Zhong-He
    Li, Feng-Peng
    Li, Wei
    Lv, Yan
    Chen, Hui-Sheng
    JOURNAL OF CLINICAL NEUROSCIENCE, 2015, 22 (01) : 83 - 86
  • [38] Clopidogrel plus aspirin for stroke prevention - Response
    Albers, GW
    Amarenco, P
    STROKE, 2002, 33 (11) : 2547 - 2547
  • [39] CARDIOVASCULAR OUTCOMES OF MONOTHERAPY WITH CLOPIDOGREL VERSUS ASPIRIN: A SYSTEMATIC REVIEW AND META-ANALYSIS
    Chaudhary, Rahul
    Kainat, Aleesha
    Pacella, John J.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2023, 81 (08) : 1209 - 1209
  • [40] Aspirin plus Clopidogrel as Secondary Prevention after Stroke or Transient Ischemic Attack: A Systematic Review and Meta-Analysis
    Zhang, Qinghua
    Wang, Chao
    Zheng, Maoyong
    Li, Yanxia
    Li, Jincun
    Zhang, Liping
    Shang, Xiao
    Yan, Chuanzhu
    CEREBROVASCULAR DISEASES, 2015, 39 (01) : 13 - 22